Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$321K Buy
35,722
+24,438
+217% +$224K ﹤0.01% 1821
2026
Q1
$105K Buy
+11,284
New +$111K ﹤0.01% 1958
2024
Q4
Sell
-3,809
Closed -$56K 2175
2024
Q3
$56K Hold
3,809
﹤0.01% 1833
2024
Q2
$57.9K Buy
3,809
+950
+33% +$13.2K ﹤0.01% 1775
2024
Q1
$34.1K Hold
2,859
﹤0.01% 1876
2023
Q4
$52K Sell
2,859
-1,020
-26% -$17.3K ﹤0.01% 1882
2023
Q3
$60K Sell
3,879
-10,480
-73% -$228K ﹤0.01% 1845
2023
Q2
$310K Hold
14,359
﹤0.01% 1491
2023
Q1
$253K Sell
14,359
-768
-5% -$14.4K ﹤0.01% 1510
2022
Q4
$270K Buy
15,127
+11,248
+290% +$160K ﹤0.01% 1479
2022
Q3
$53K Buy
+3,879
New +$78.1K ﹤0.01% 1659

Other funds holding NEOG

Amundi's NEOG Position: Q2 2026 in Review

Amundi increased its Neogen (NEOG) stake by 217% in Q2 2026, buying an estimated $224K and bringing the position to 35,722 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #1821.

Amundi first reported a position in NEOG in Q3 2022 and has held it in 11 quarters since. 317 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • Amundi held 35,722 shares of Neogen worth $321K as of Q2 2026.
  • Amundi bought 24,438 Neogen shares in Q2 2026, an estimated $224K.
  • Neogen made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1821 holding.
  • Amundi first reported a position in Neogen in Q3 2022 and has held it in 11 quarters since.
  • 317 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.